You just read:

Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT

News provided by

Milestone Pharmaceuticals, Inc.

Oct 03, 2019, 07:00 ET